EphA4 defines a class of excitatory locomotor-related interneurons.

EphA4 defines a class of excitatory locomotor-related interneurons.

Relatively little is known about the interneurons that constitute the mammalian locomotor central pattern generator and how they interact to produce behavior. A potential avenue of research is to identify genetic markers specific to interneuron populations that will assist further exploration of the...

Descripció completa

Dades bibliogràfiques
Autors principals:	Butt, S, Lundfald, L, Kiehn, O
Format:	Journal article
Idioma:	English
Publicat:	2005

Ítems similars

Phenotype of V2-derived interneurons and their relationship to the axon guidance molecule EphA4 in the developing mouse spinal cord.
per: Lundfald, L, et al.
Publicat: (2007)

Role of EphA4 and EphrinB3 in local neuronal circuits that control walking.
per: Kullander, K, et al.
Publicat: (2003)

Ephrin Receptors (Eph): EphA1, EphA5, and EphA7 Expression in Uveal Melanoma—Associations with Clinical Parameters and Patient Survival
per: Malgorzata Gajdzis, et al.
Publicat: (2020-09-01)

Targeting EphA2 in cancer
per: Ta Xiao, et al.
Publicat: (2020-08-01)

EphA2 Is a Therapy Target in EphA2-Positive Leukemias but Is Not Essential for Normal Hematopoiesis or Leukemia.
per: Sara Charmsaz, et al.
Publicat: (2015-01-01)

Development of an In-House EphA2 ELISA for Human Serum and Measurement of Circulating Levels of EphA2 in Hypertensive Patients with Renal Dysfunction
per: Maki Murakoshi, et al.
Publicat: (2022-12-01)

Peripheral loss of EphA4 ameliorates TBI-induced neuroinflammation and tissue damage
per: Elizabeth A. Kowalski, et al.
Publicat: (2019-11-01)

Theoretical Model of EphA2-Ephrin A1 Inhibition
per: Wiktoria Jedwabny, et al.
Publicat: (2018-07-01)

Drug-resistant cancer cell-derived exosomal EphA2 promotes breast cancer metastasis via the EphA2-Ephrin A1 reverse signaling
per: Zicong Gao, et al.
Publicat: (2021-04-01)

Structures of the EphA2 receptor at the membrane: Role of lipid interactions
per: Chavent, M, et al.
Publicat: (2017)

Targeting the EphA2 pathway: could it be the way for bone sarcomas?
per: Giorgia Giordano, et al.
Publicat: (2024-09-01)

EphA‐Mediated Regulation of Stomatin Expression in Prostate Cancer Cells
per: Masanari Nishida, et al.
Publicat: (2024-10-01)

Inhibition of VEGF-Dependent Multistage Carcinogenesis by Soluble EphA Receptors
per: Nikki Cheng, et al.
Publicat: (2003-09-01)

Optimizing EphA2-CAR T Cells for the Adoptive Immunotherapy of Glioma
per: Zhongzhen Yi, et al.
Publicat: (2018-06-01)

EphA7 isoforms differentially regulate cortical dendrite development.
per: Carrie E Leonard, et al.
Publicat: (2020-01-01)

Effects of Eph/ephrin signalling and human Alzheimer's disease-associated EphA1 on Drosophila behaviour and neurophysiology
per: Edgar Buhl, et al.
Publicat: (2022-08-01)

EphA4 expression promotes network activity and spine maturation in cortical neuronal cultures
per: Clifford Meredith A, et al.
Publicat: (2011-05-01)

Preclinical and Toxicology Assessment of ALW-II-41-27, an Inhibitor of the Eph Receptor A2 (EphA2)
per: Theodore J. Kottom, et al.
Publicat: (2024-08-01)

Unveiling the therapeutic promise of EphA2 in glioblastoma: a comprehensive review
per: Caohang Qiu, et al.
Publicat: (2024-09-01)

EphA3 CAR T cells are effective against glioblastoma in preclinical models
per: Xiang Li, et al.
Publicat: (2024-08-01)

#50. Investigating the role of EphA2 in breast cancer bone metastasis
per: Verra Ngwa, et al.
Publicat: (2024-04-01)

Effective Tumor Targeting by EphA2-Agonist-Biotin-Streptavidin Conjugates
per: Parima Udompholkul, et al.
Publicat: (2021-06-01)

EphA7 promotes myogenic differentiation via cell-cell contact
per: Laura L Arnold, et al.
Publicat: (2020-04-01)

Upregulation of EphA Receptor Expression in the Injured Adult Rat Spinal Cord
per: Christopher A. Willson, et al.
Publicat: (2002-04-01)

Role of EphA2 in host defense against oro-pharyngeal candidiasis
per: Ingar Olsen
Publicat: (2020-01-01)

EphA2 contributes to disruption of the blood-brain barrier in cerebral malaria.
per: Thayer K Darling, et al.
Publicat: (2020-01-01)

Engineering of monobody conjugates for human EphA2-specific optical imaging.
per: Min-A Kim, et al.
Publicat: (2017-01-01)

Anti-EphA2 Antibodies Decrease EphA2 Protein Levels in Murine CT26 Colorectal and Human MDA-231 Breast Tumors But Do Not Inhibit Tumor Growth
per: David Kiewlich, et al.
Publicat: (2006-01-01)

EphA4 Negatively Regulates Myelination by Inhibiting Schwann Cell Differentiation in the Peripheral Nervous System
per: Ruyue Chen, et al.
Publicat: (2019-11-01)

EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells.
per: Xiao-Dong Dong, et al.
Publicat: (2023-05-01)

Modeling development in retinal afferents: retinotopy, segregation, and ephrinA/EphA mutants.
per: Keith B Godfrey, et al.
Publicat: (2014-01-01)

The identification and validation of EphA7 hypermethylation, a novel biomarker, in cervical cancer
per: Wenfan Zhang, et al.
Publicat: (2022-06-01)

Interactions of the EphA2 kinase domain with PIPs in membranes: implications for receptor function
per: Chavent, M, et al.
Publicat: (2018)

Structurally encoded intraclass differences in EphA clusters drive distinct cell responses
per: Seiradake, E, et al.
Publicat: (2013)

Structurally encoded intraclass differences in EphA clusters drive distinct cell responses.
per: Seiradake, E, et al.
Publicat: (2013)

Therapeutic Targeting of Pancreatic Cancer via EphA2 Dimeric Agonistic Agents
per: Ahmed F. Salem, et al.
Publicat: (2020-05-01)

Overexpression of hepatocyte EphA2 enhances liver-stage infection by Plasmodium vivax
per: Sittinont Chainarin, et al.
Publicat: (2022-12-01)

COMPLEMENTARY EXPRESSION OF EphA7 AND SCO-SPONDIN DURING POSTERIOR COMMISSURE DEVELOPMENT
per: Karen eStanic, et al.
Publicat: (2014-06-01)

Molecular basis of EphA2 recognition by gHgL from gammaherpesviruses
per: Chao Su, et al.
Publicat: (2020-11-01)

Patterned Substrate of Mobile and Immobile Ligands to Probe EphA2 Receptor Clustering
per: Zhongwen Chen, et al.
Publicat: (2022-06-01)